Health insurers and medical providers are fighting over who should provide high-cost infusion drugs for patients, with the fight over profits now spilling into state homes across the country. The problem is that some insurers are bypassing hospital pharmacies and doctor’s offices and instead shipping more complex drugs through third-party pharmacies. Those pharmacies then ship … Read more
Federal regulators want most patients to see a healthcare provider in person before receiving prescriptions for potentially addictive drugs through telehealth, which hasn’t been required in more than three years. During the covid-19 public health emergency, the Drug Enforcement Administration has allowed doctors and other healthcare professionals to prescribe controlled medications during telehealth appointments without … Read more
Canadian government proposes new Agile licensing framework to accelerate pre-market regulation of pharmaceutical products. While Health Minister Jean-Yves Duclos says this is part of the government’s strategy to give Canadians access to quality, affordable medicines, the policy is likely to cause more harm than good. Adopting Agile Licensing would allow companies to market drugs up … Read more
Isometric illustration of a liver test. NASH is a condition caused by liver dysfunction. Credit: Mono via Getty Images Following a negative decision by the US Food and Drug Administration (FDA) for Intercept Pharmaceuticals Ocaliva (obeticholic acid), all eyes are now on the next possible drug to lead the race to market for nonalcoholic steatohepatitis … Read more